Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Different capacity of monocyte subsets to phagocytose iron-oxide nanoparticles.

PloS one - 1 Jan 2011

Settles Marcus, Etzrodt Martin, Kosanke Katja, Schiemann Matthias, Zimmermann Alexander, Meier Reinhard, Braren Rickmer, Huber Armin, Rummeny Ernst J, Weissleder Ralph, Swirski Filip K, Wildgruber Moritz

Abstract excerpt

OBJECTIVE: To explore the capacity of human CD1⁺CD16⁺⁺ and CD14⁺⁺CD16⁻ monocytes to phagocyte iron-oxide nanoparticles in vitro. METHODS: Human monocytes were labeled with four different magnetic nanoparticle preparations (Ferumoxides, SHU 555C, CLIO-680, MION-48) exhibiting distinct properties and cellular uptake was quantitatively assessed by flow cytometry, fluorescence microscopy, atomic absorption...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ferric Compounds
Share to Intracellular Space

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Magnetic Resonance Spectroscopy

Share to Monocytes

Share to Nanoparticles

Share to Phagocytosis

Share to Spectrophotometry, Atomic

Share to Staining and Labeling

Source

Open in PubMed Open full text

Identifiers

PMID: 21984904
DOI: 10.1371/journal.pone.0025197
PMCID: PMC3184946

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Different capacity of monocyte subsets to phagocytose iron-oxide nanoparticles.PMID 21984904Read ↗

Nanoparticles Targeting Monocytes and Macrophages as Diagnostic and Therapeutic Tools for Autoimmune DiseasesSemantic proximity Read ↗

Monocyte subset dynamics in human atherosclerosis can be profiled with magnetic nano-sensors.Semantic proximity Read ↗

The Macrophage Iron Signature in Health and DiseaseSemantic proximity Read ↗

Design of a Robust Flow Cytometric Approach for Phenotypical and Functional Analysis of Human Monocyte Subsets in Health and Disease.Semantic proximity Read ↗

The Use of Iron Oxide Nanoparticles to Reprogram Macrophage Responses and the Immunological Tumor Microenvironment.Semantic proximity Read ↗

The Double-Edged Sword Effect of Macrophage Targeting Delivery System in Different Macrophage Subsets Related DiseasesSemantic proximity Read ↗

Phenotype Determines Nanoparticle Uptake by Human Macrophages from Liver and Blood.Semantic proximity Read ↗

Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes.Semantic proximity Read ↗

Macrophage Phenotype-Dependent Protein Corona Formation Governs Ligand Accessibility and Immune Clearance of Biomimetic Nanoparticles.Semantic proximity Read ↗

Non-Genetic Reprogramming of Monocytes via Microparticle Phagocytosis for Sustained Modulation of Macrophage PhenotypeSemantic proximity Read ↗

Nanoparticle endocytosis is driven by monocyte phenotype rather than nanoparticle size under high shear flow conditionsSemantic proximity Read ↗

Quantitative Magnetic Flow Cytometry in High Hematocrit Conditions for Point-of-Care TestingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.